UPMC HEART AND VASCULAR INSTITUTE | UNIVERSITY OF PITTSBURGH | FIND PEOPLE
VMI
 


Vascular Medicine Institute
University of Pittsburgh
BST E1240
200 Lothrop Street
Pittsburgh, PA 15261
Phone: 412-383-5853
Fax: 412-648-5980

Benign Hematology Clinical and Research Faculty and Programs

 

Vascular Biology, Platelets, and Hemostasis

MATTHEW NEAL, MD
Hemostasis, Inflammation, Thrombosis, Trauma, and Transfusion Surgical Outcomes (HIT3S) Research Group

MARGARET RAGNI, MD, MPH
Novel therapies for hemophilia and Von Willebrand Disease (VWD)

MARK GLADWIN, MD
Donor genetic variations can affect hemolytic propensity and RBC storage recovery and function

YINGZE ZHANG, PhD
Genetic Control of Thrombospondin Transcription and Vasculopathy in Sickle Cell Disease

ENRICO NOVELLI, MD, MS
Novel Biomarkers in Sickle Cell Anemia

SRUTI SHIVA, PhD
Mitochondria, Platelets, and Heme

KARIN POTOKA, MD
Soluble guanylyl cyclase stimulation as a potential treatment in sickle cell disease

 

 

 


Iron, Heme, and Globins

GRANT BULLOCK, MD, PhD
Aconitase: an iron-sensing regulator of mitochondrial oxidative metabolism and erythropoiesis

JOSEPH KISS, MD
Impact of Iron Status and Anemia in Blood Donors... Does it Matter for RBC Transfusion Therapy

PAOLA CORTI, PhD
Investigating the function of zebrafish globins in development and heart generation

ADAM STRAUB, PhD
Mechanisms of heme redox regulation

TAMIR KANIAS, PhD
Red Blood Cells

AISHA WALKER, PhD
Cellular and Molecular Mediators of Fetal Hemoglobin Expression: The Land Before Blood Cells

 


TLR4 and the Immune System

LISA BORGHESI, PhD
Role of Toll-like receptors in hematopoiesis

GREGORY KATO, MD
Heme, Inflammasome, and Sickle Cell Disease

PARTHA DUTTA, DVM, PhD
Hematopoiesis in Cardiovascular Disease

SOLOMON OFORI-ACQUAH, PhD
Extracellular heme: a prototypical erythroid DAMP molecule and effector pathogen of sickle crisis

CHERYL HILLERY, MD
HMGB1 and TLR4 in Sickle Cell Disease

PRITHU SUNDD, PhD
Role of platelet TLR4, NLRP3-inflammasome and extracellular vesicles in sickle cell disease

 


Something Old, Something New

FRANKLIN BONTEMPO, MD
HCWP

LAURA DE CASTRO, MD, MHSc
Translation from Biology to Clinical Trials in Sickle Cell Disease

CHARLES JONASSAINT, PhD
Using Mobile Technology to Bridge Gaps in Sickle Cell Disease Care

DARRELL TRIULZI, MD
Anti-fibrinolytic Agents in the Management of Thrombocytopenia